Vývoj prevalence diabetu a nákladů na jeho léčbu a prevenci v České republice v letech 2015 až 2022

The aim of this bachelor thesis is to analyze the development of costs associated with the treatment and prevention of diabetes in the Czech Republic in the period 2015–2022. Given the growing number of people with diabetes, this issue represents a significant challenge for public health and the economy. At the same time, emphasis is placed on identifying the economic impact of this disease and the costs associated with its treatment. The theoretical part focuses on the analysis of the healthcare system in the Czech Republic, with an emphasis on the functioning of public health insurance, insurance companies, and diabetic-related benefits. The practical part provides a quantitative and comparative analysis of the prevalence and incidence of diabetes and the costs of its treatment. Furthermore, the impact of the COVID-19 pandemic on this issue is analyzed. The results show that the costs associated with the treatment and prevention of diabetes are rising in the long term. This growth is caused by the increasing number of patients, the growing technological complexity of treatment, and insufficient prevention. The results also revealed that the structure of clients of individual insurance companies influences the potential impacts of macroeconomic shocks on the prevalence of diabetes and related costs. A comparative analysis with selected OECD countries shows that the Czech Republic has a higher prevalence of diabetes in comparison with more developed countries such as France and Denmark which have been allocating more funds to prevention programs in the long-term. Based on these results it is clear, that current healthcare expenditures are allocated more to the treatment of the consequences of diabetes than to its effective prevention.